Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Aug 13 2021

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-aug-13-2021-7

Cadila Healthcare Limited has informed the Exchange regarding a press release dated August 13, 2021, titled "Zydus Cadila receives final approval from USFDA for Mesalamine Extended-Release Capsules".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases